Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.
about
EVIDENCE OF INCREASING DIVERSIFICATION OF ZIKA VIRUS STRAINS ISOLATED IN THE AMERICAN CONTINENT.Functional Analysis of Glycosylation of Zika Virus Envelope Protein.Zika virus reservoirs: Implications for transmission, future outbreaks, drug and vaccine development.Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium.Mitigating the risk of Zika virus contamination of raw materials and cell lines in the manufacture of biologicals.Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model.The Zika Virus Epidemic in Brazil: From Discovery to Future Implications.How Do Virus-Mosquito Interactions Lead to Viral Emergence?Small Molecules and Antibodies for Zika Therapy.Zika virus can be venereally transmitted between Aedes aegypti mosquitoes.Age and Gender in the Zika Pandemic Era.Haiku: New paradigm for the reverse genetics of emerging RNA viruses.Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.Prediction and prevention of urban arbovirus epidemics: A challenge for the global virology community.Did Zika Virus Mutate to Cause Severe Outbreaks?The Antiviral Drug Arbidol Inhibits Zika Virus.Zika vaccines and therapeutics: landscape analysis and challenges ahead.Biochemistry and Molecular Biology of Flaviviruses.Evolution of Two Major Zika Virus Lineages: Implications for Pathology, Immune Response, and Vaccine DevelopmentColonized , a Sylvatic New World Mosquito Species, Shows a Low Vector Competence for Zika Virus Relative toAn Update on Sexual Transmission of Zika VirusUse of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections
P2860
Q38156872-45A217C4-EDAB-4706-9164-EDDC401B4E5EQ43046946-0D38802E-D22B-450F-A230-9CB7CCD8D24AQ45323553-758CA25B-E789-41F0-9F5E-BE80CEE45C33Q45323864-C883C740-6184-462C-8248-4FFA14BF7CEEQ46946739-506C2E48-15D4-4F11-A878-59E807AB812FQ47197092-59C31870-6D88-4A99-BFD7-6629635427EAQ47556656-06351746-1423-40D6-98F7-8E779CE3403AQ47557749-5492B245-8764-4B3D-93F5-F7E72561DDB5Q47558373-0C9EBF39-0090-4D13-9032-0FFDC4E20F99Q47558508-33C71AFD-C24D-4E72-89CE-4BB27C5E59D1Q47558649-D8AA0464-2C10-40AB-8C1F-46E71616CA72Q50041776-2F8C38B7-5DF9-45FF-AF7C-E87CE69CA4F7Q50192364-E992CBBE-327D-420C-8E31-54307B860D2CQ51336011-2D5F4A73-D523-4068-970C-07D8B4E9A3E3Q55084344-A0E490A6-315A-42D1-A49A-51E512BEC312Q55084350-F1A886EF-6298-4791-9A7B-7DEE21240B13Q55084371-BDC1D764-7B28-4846-BFD3-6BCF34A07575Q55084405-047707D8-AAF1-4324-972F-FD6AEE6B7F7BQ55277816-BB38747C-FBB3-49F7-8FEC-9BC6683E70C5Q56000988-1CFF5438-1C54-4C23-820E-EE1C2BCEAEC0Q56339939-1A57657E-837E-4BBE-A3EF-807DCB2299E9Q56341896-024314FB-9F10-457D-9300-82FB9C46880CQ56350169-2478F53E-149A-4AE4-A9C4-6A18443E0F89
P2860
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Zika in the Americas, year 2: ...... from the Global Virus Network.
@ast
Zika in the Americas, year 2: ...... from the Global Virus Network.
@en
type
label
Zika in the Americas, year 2: ...... from the Global Virus Network.
@ast
Zika in the Americas, year 2: ...... from the Global Virus Network.
@en
altLabel
Zika in the Americas, year 2: ...... from the Global Virus Network
@en
prefLabel
Zika in the Americas, year 2: ...... from the Global Virus Network.
@ast
Zika in the Americas, year 2: ...... from the Global Virus Network.
@en
P2093
P2860
P50
P921
P1433
P1476
Zika in the Americas, year 2: ...... from the Global Virus Network.
@en
P2093
Caroline Marrs
Christina Gavegnano
Edward McSweegan
Geraldine O Schott-Lerner
Leda Bassit
Matthew T Aliota
Natalia Mercer
Shelton S Bradrick
P2860
P304
P356
10.1016/J.ANTIVIRAL.2017.06.001
P50
P577
2017-06-05T00:00:00Z